Stay updated on HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T14:48:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T10:32:21.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    59 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T22:10:20.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T14:42:52.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T10:34:36.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T02:00:08.000Z thumbnail image

Stay in the know with updates to HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.